How long can we live?
The increase in the elderly population in developed economies raises questions about trends in life expectancy, age-specific mortality and morbidity. Greater understanding of the dynamics of ageing will help us improve provision of health and social care; as well as addressing the pressing need of funding an ageing population.
| Date | 27 Oct 2020 |
|---|---|
| Host | Swiss Re Institute |
| Location | Online Click to open location details |
Tab navigation
Agenda of episode 3
|
Date |
27 October 2020 |
|---|---|
|
Speakers |
Nir Barzilai, Professor of Medicine and Genetics, Director of the Institute for Aging Research, Albert Einstein College of Medicine |
The increase in the elderly population in developed economies raises questions about trends in life expectancy, age-specific mortality and morbidity. Greater understanding of the dynamics of ageing will help us improve provision of health and social care; as well as addressing the pressing need of funding an ageing population.
The session considered many of the biological questions and uncertainties surrounding ageing. What are the drivers of mortality rates in old age and how will they develop over the next 20 years? Is there an upper limit to life expectancy or will we see further increases? What do we know about the biology of ageing? Can some of its effects be reversed, and the period of healthy life span be extended?
In episode 3 of "The Ageing Effect", we were joined by Nir Barzilai, Director of the Institute for Aging Research, Albert Einstein College of Medicine, and recent author of "Age later", and by John Schoonbee, Global Chief Medical Officer, Swiss Re
“The Ageing Effect” is a four-part series by Swiss Re Institute and Asia Society Switzerland exploring the effects of demographic change on Asia and the World.
SPEAKERS Meet our speakers
